PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 40 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

21 June 2025

  1. (diff | hist) 19:14 Bachem Holding (Suzhou) 11,853 +265 PurityClaimPia (talk | contribs) add the standing talk-page note link to the banner [rollback]
  2. (diff | hist) m 18:33 Intention-to-treat analysis 4,637 ±0 TFA_Counterion (talk | contribs) add the number randomised and the number completing [rollback]
  3. (diff | hist) m 13:51 Repackaging 4,506 +548 CustomsClarke (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  4. (diff | hist) 12:34 Cagrilintide 4,052 +839 LiraLotte (talk | contribs) add CAS number, sourced [rollback]
  5. (diff | hist) m b 11:23 Loss on drying 4,381 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  6. (diff | hist) 07:27 Tianjin Finder Chemical 8,980 +485 AnaesthesiaAoife (talk | contribs) attribute the capability claim to the organisation's own material [rollback]
  7. (diff | hist) 06:04 Insulin syringe 4,667 ±0 HalfLifeHavel (talk | contribs) state the number of doses a vial yields at that concentration [rollback]

20 June 2025

  1. (diff | hist) 19:17 Sangon Biotech 8,781 +389 EndotoxinEd (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  2. (diff | hist) 14:45 Enteroendocrine L cell 5,083 +435 AmylinAmos (talk | contribs) rm the sentence implying the hormone is a drug [rollback]
  3. (diff | hist) 12:41 Patent expiry and biosimilars 3,580 ±0 Chromatokid (talk | contribs) clarify the difference between a marketing authorisation and a registration [rollback]
  4. (diff | hist) m 11:03 Active pharmaceutical ingredient 3,755 ±0 BiosimilarBoaz (talk | contribs) attribute the compounding statement to the pharmacy board that issued it [rollback]
  5. (diff | hist) m 08:48 Bacterial endotoxin test 5,088 +660 PatientPanelPru (talk | contribs) expand §Why it matters for peptide material [rollback]

19 June 2025

  1. (diff | hist) 23:33 PeptideMeter 4,694 ±0 CrossRefCleve (talk | contribs) add the cross-link to the traceability article [rollback]
  2. (diff | hist) m b 14:42 HOMA-IR 4,218 +755 CiteBot (talk | contribs) bot: normalise unit spacing [rollback]
  3. (diff | hist) 14:38 Arcuate nucleus 4,363 ±0 BPC_Bramwell (talk | contribs) add see also to the sister hormone [rollback]
  4. (diff | hist) 12:18 Purity claim inflation 5,156 +561 A1c_Alder (talk | contribs) convert the service comparison to a table [rollback]
  5. (diff | hist) 11:15 Lyophilisation 23,183 +568 SupplyWatchSuri (talk | contribs) add the light-exposure point for photosensitive material [rollback]
  6. (diff | hist) m 08:43 Qingdao Saber Technology Pharmaceutical 2,492 +374 GroupBuyGalen (talk | contribs) fix the anchor on an internal link [rollback]
  7. (diff | hist) 06:42 USP General Chapter 71 4,070 +707 PeakShapePol (talk | contribs) expand §What the chapter specifies [rollback]
  8. (diff | hist) 06:26 Oral semaglutide 3,542 ±0 LiraLotte (talk | contribs) add the receptor targets to the lead sentence [rollback]
  9. (diff | hist) 03:14 Area percent purity 6,764 +166 ColdChainCleo (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]

18 June 2025

  1. (diff | hist) 19:39 Deamidation 4,219 ±0 ResolutionRoo (talk | contribs) add the repeatability figure with the number of injections [rollback]
  2. (diff | hist) m 18:12 Solid-phase peptide synthesis 5,359 ±0 FormularyFrida (talk | contribs) fix a dangling clause [rollback]
  3. (diff | hist) 13:08 Xi'an Mokemei Biotechnology 7,057 +732 IncretinIvo (talk | contribs) serial comma per PP:MOS [rollback]
  4. (diff | hist) 03:33 SinoPep 2,939 +998 Ref_Desk_Ron (talk | contribs) state the city and province of the registered address [rollback]

17 June 2025

  1. (diff | hist) m 23:30 Custom peptide synthesis 4,548 +36 BlindSampleBrid (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  2. (diff | hist) m 23:26 Shanghai Wibson Biotechnology 8,222 +124 BatchNumberBede (talk | contribs) de-orphan [rollback]
  3. (diff | hist) N 23:12 SinoPep 1,941 +1,941 BlindSampleBrid (talk | contribs) new article: supplier organisation, created after the notability discussion
  4. (diff | hist) m 19:17 Blind sampling 7,309 ±0 PurityClaimPia (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  5. (diff | hist) m b 17:11 Satiety signalling 5,245 +775 CategoryBot (talk | contribs) bot: expand PMID to full citation [rollback]
  6. (diff | hist) m 13:42 Limit of detection 4,001 ±0 AnalyticalAnnie (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]
  7. (diff | hist) m 13:30 Placebo-adjusted effect 4,581 +688 LeaderLoic (talk | contribs) give the absolute risk difference alongside the relative one [rollback]
  8. (diff | hist) m b 13:15 Exenatide 4,472 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  9. (diff | hist) 10:31 Talk:SinoPep 1,244 +182 ScopeSeverin (talk | contribs) /* Notability, and whether a documentary distinction is a notable one */ reply
  10. (diff | hist) 08:42 Regulatory status by jurisdiction 4,230 +568 FiveOhThreeB (talk | contribs) ce [rollback]
  11. (diff | hist) 07:19 Sigma-Aldrich (Shanghai) Trading 7,638 +673 ReportReaderRilla (talk | contribs) expand §Independent testing record [rollback]
  12. (diff | hist) m 05:45 Number needed to treat 4,498 +867 StudentSindhu (talk | contribs) expand §Number needed to harm [rollback]
  13. (diff | hist) 05:03 Semaglutide 8,560 ±0 IcodecIndra (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  14. (diff | hist) m 04:42 Qingdao Sigma Chemical 12,060 +478 SortKeySascha (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]

16 June 2025

  1. (diff | hist) m b 22:54 Insulin syringe unit conversion 5,079 +635 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) 22:05 Peptide stability table 5,122 +231 NPOV_Nadia (talk | contribs) add the medical-disclaimer cross-link to the tool pages [rollback]
  3. (diff | hist) 16:20 STEP trial programme 5,114 +723 PioneerPerdita (talk | contribs) consistent en dashes in ranges [rollback]
  4. (diff | hist) m b 13:32 Guangzhou JEEP Biotechnology 12,241 +53 ArchiveBot (talk | contribs) bot: add supplier category [rollback]
  5. (diff | hist) 10:20 Customs seizure 3,644 ±0 ImportRecordIna (talk | contribs) add the year the guidance was issued [rollback]
  6. (diff | hist) 09:55 Zhuhai Kerui Biotechnology 4,194 +1,443 Hedgerow_Hal (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  7. (diff | hist) 08:21 Crude peptide 3,938 ±0 SPPS_Sorrel (talk | contribs) add the light-exposure point for photosensitive material [rollback]
  8. (diff | hist) 04:45 Sarcopenia 3,762 ±0 eGFR_Esme (talk | contribs) attribute the population interval to the cohort it was derived from [rollback]

15 June 2025

  1. (diff | hist) m 21:06 Flourishglobal Peptide Biotech 6,884 +377 VerifyFirstVida (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  2. (diff | hist) 19:26 Temperature excursion 10,117 +652 Chromatokid (talk | contribs) add the cross-link to the temperature-excursion article [rollback]
  3. (diff | hist) 18:09 Karl Fischer titration 7,949 ±0 SecondarySrc_Seb (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]
  4. (diff | hist) 18:04 GL Biochem (Shanghai) 14,316 ±0 UnderfillUna (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]
  5. (diff | hist) 17:05 TRIUMPH trial programme 4,035 ±0 FlowTrialFraser (talk | contribs) expand §What phase 3 is designed to address [rollback]
  6. (diff | hist) 14:50 GLP-1 receptor agonist 9,758 ±0 IcodecIndra (talk | contribs) serial comma per PP:MOS [rollback]
  7. (diff | hist) m 14:31 Glucagon-like peptide-1 11,430 +201 AmylinAmos (talk | contribs) correct the second-messenger pathway named in the lead [rollback]
  8. (diff | hist) 14:00 CagriSema 4,185 +18 TrialsTabitha (talk | contribs) add see also to the amylin analogue [rollback]
  9. (diff | hist) m 10:50 SELECT trial 4,851 ±0 DataTableDunja (talk | contribs) add the trial acronym expansion at first use [rollback]
  10. (diff | hist) m 08:25 Methionine oxidation 3,850 ±0 MassSpecMarv (talk | contribs) expand §Detection and control [rollback]
  11. (diff | hist) m b 04:13 Fasting insulin 3,910 ±0 CategoryBot (talk | contribs) bot: update parent category chain [rollback]

14 June 2025

  1. (diff | hist) m 21:07 Dipeptidyl peptidase-4 6,468 +446 EmptyingElke (talk | contribs) add the counter-regulatory glucagon point, sourced [rollback]
  2. (diff | hist) 19:50 Hypoglycaemia 4,417 +642 SVG_Solomon (talk | contribs) expand §Why glucose dependence matters [rollback]
  3. (diff | hist) m b 10:35 Receptor bias 4,000 +464 CiteBot (talk | contribs) bot: sort category members [rollback]
  4. (diff | hist) m 10:07 Hunan Aslsen Technology 10,654 +590 VerifyFirstVida (talk | contribs) expand §External links [rollback]
  5. (diff | hist) 08:29 Prior authorisation 3,517 ±0 RfC_Rasmus (talk | contribs) add the cross-link to the insurance article [rollback]
  6. (diff | hist) 08:07 ChinaPeptides 9,511 +199 LedgerLysander (talk | contribs) expand §Reception [rollback]
  7. (diff | hist) 05:42 Drug master file 4,092 +750 EndotoxinEd (talk | contribs) add the jurisdiction to the legal statement [rollback]
  8. (diff | hist) m 03:34 Retention time 3,764 +428 OffLabelOdile (talk | contribs) sentence case in headings per PP:MOS [rollback]
  9. (diff | hist) 00:17 Grey market 3,461 ±0 Chromatokid (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]

13 June 2025

  1. (diff | hist) 12:15 Preparative HPLC purification 4,598 ±0 BetaCellBoyd (talk | contribs) expand §Scale-up [rollback]
  2. (diff | hist) 12:13 Trifluoroacetate counterion 3,918 +19 LotTraceLuka (talk | contribs) space between number and unit per PP:MOS [rollback]
  3. (diff | hist) 11:20 Talk:SinoPep 1,033 +172 NPOV_Nadia (talk | contribs) /* Notability, and whether a documentary distinction is a notable one */ reply
  4. (diff | hist) 10:18 Talk:Shanghai Sigma-Audley New Material Technology 1,170 +85 COA_Colwyn (talk | contribs) /* Packaging consistency: observation or compliment? */ reply
  5. (diff | hist) 10:02 Talk:Zhuhai Kerui Biotechnology 1,033 +81 PuffRemoverPax (talk | contribs) /* Method disclosure: are we writing an endorsement? */ reply
  6. (diff | hist) 08:54 Reference standard 4,806 ±0 DiluentDiya (talk | contribs) ce per PP:MOS [rollback]
  7. (diff | hist) m 08:27 Qingdao Saber Technology Pharmaceutical 2,118 +360 TirzTaxonomist (talk | contribs) sentence case in headings per PP:MOS [rollback]
  8. (diff | hist) m 07:40 Peptide 6,609 ±0 CounterfeitCato (talk | contribs) move a stray full stop inside the reference [rollback]
  9. (diff | hist) m 04:49 Hubei Jianxiang Bioscience 6,109 +630 TallySheetTad (talk | contribs) rm the adjective — an organisation article describes, it does not praise [rollback]
  10. (diff | hist) m 00:14 Cost per milligram 3,292 ±0 SecretagogueSol (talk | contribs) add the compounded-alternative point with its regulatory caveat [rollback]

12 June 2025

  1. (diff | hist) m 20:03 Baseline laboratory panel 4,222 ±0 DataTableDunja (talk | contribs) expand §Common components [rollback]
  2. (diff | hist) 12:39 Reverse-phase HPLC 5,116 ±0 SigFigSindri (talk | contribs) add the equilibration time to the gradient description [rollback]
  3. (diff | hist) 12:04 Gastric emptying 5,258 +606 LCellLeif (talk | contribs) add the species in which the knockout work was done [rollback]
  4. (diff | hist) m 11:07 Batch number 4,286 +555 BlindSampleBrid (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  5. (diff | hist) 08:55 Talk:Shanghai Sigma-Audley New Material Technology 959 +204 PrimarySrcPatia (talk | contribs) /* Packaging consistency: observation or compliment? */ reply
  6. (diff | hist) 08:49 Proglucagon 6,144 +401 ArcuateArt (talk | contribs) add short description [rollback]
  7. (diff | hist) 08:41 Talk:Temperature excursion 822 +186 ColdChainCleo (talk | contribs) /* Worked MKT example: check of the arithmetic */ reply
  8. (diff | hist) 08:19 Talk:Certificate of analysis 1,096 +79 HyphenHarriet (talk | contribs) /* Should the requested-items list be numbered? */ reply
  9. (diff | hist) 07:41 Talk:Glucagon-like peptide-1 1,370 +111 BaselineBex (talk | contribs) /* Should the fasting concentration range be in the infobox? */ reply
  10. (diff | hist) 06:30 Fmoc chemistry 4,618 +188 GHK_Gwendolen (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]
  11. (diff | hist) m 05:54 Liraglutide 5,268 ±0 DrTitration (talk | contribs) expand §Practical differences from weekly agents [rollback]
  12. (diff | hist) 05:39 Glucose-dependent insulinotropic polypeptide 6,898 ±0 EmptyingElke (talk | contribs) add a figure for the secretion time course and caption it [rollback]

11 June 2025

  1. (diff | hist) 23:56 Trial data comparison 5,448 +523 EscalationEira (talk | contribs) label the filter control so its state is announced [rollback]
  2. (diff | hist) 22:26 Resin cleavage 4,029 +725 SPPS_Sorrel (talk | contribs) expand §Cocktails and scavengers [rollback]
  3. (diff | hist) m b 22:14 Beyond-use date 15,368 +1,696 StubSorterBot (talk | contribs) bot: add stub category [rollback]
  4. (diff | hist) 15:26 Talk:Certificate of analysis 885 +237 Retention_Time_Rae (talk | contribs) /* Should the requested-items list be numbered? */ reply
  5. (diff | hist) 13:02 Talk:Shanghai Sigma-Audley New Material Technology 748 +222 StyleSheetSybil (talk | contribs) /* Packaging consistency: observation or compliment? */ reply
  6. (diff | hist) 12:07 Talk:Temperature excursion 611 +233 StabilityStig (talk | contribs) /* Worked MKT example: check of the arithmetic */ reply
  7. (diff | hist) 10:08 Talk:Certificate of analysis 674 +130 HyphenHarriet (talk | contribs) /* Should the requested-items list be numbered? */ new section
  8. (diff | hist) 10:02 Talk:Glucagon-like peptide-1 1,159 +247 AnalyticalAnnie (talk | contribs) /* Should the fasting concentration range be in the infobox? */ reply
  9. (diff | hist) 09:40 Talk:Shanghai Sigma-Audley New Material Technology 537 +366 COA_Colwyn (talk | contribs) /* Packaging consistency: observation or compliment? */ new section
  10. (diff | hist) 09:35 Talk:Zhuhai Kerui Biotechnology 822 +230 Hedgerow_Hal (talk | contribs) /* Method disclosure: are we writing an endorsement? */ reply
  11. (diff | hist) 09:33 Talk:Temperature excursion 400 +402 UnitAuditUwe (talk | contribs) /* Worked MKT example: check of the arithmetic */ new section